SUSE: 2020:1285-1 Important: python-PyYAML Arbitrary Code Execution
suse
May 15, 2020
An update that fixes one vulnerability is now available
Summary
This update for python-PyYAML fixes the following issues: - CVE-2020-1747: Fixed an arbitrary code execution when YAML files are parsed by FullLoader (bsc#1165439). Patch Instructions: To install this SUSE Security Update use the SUSE recommended installation methods like YaST online_update or "zypper patch". Alternatively you can run the command listed for your product: - SUSE OpenStack Cloud Crowbar 8: zypper in -t patch SUSE-OpenStack-Cloud-Crowbar-8-2020-1285=1 - SUSE OpenStack Cloud 8: zypper in -t patch SUSE-OpenStack-Cloud-8-2020-1285=1 - SUSE OpenStack Cloud 7: zypper in -t patch SUSE-OpenStack-Cloud-7-2020-1285=1 - SUSE OpenStack Cloud 6-LTSS: zypper in -t patch SUSE-OpenStack-Cloud-6-LTSS-2020-1285=1 - SUSE Manager Tools 12: zypper in -t patch SUSE-SLE-Manager-Tools-12-2020-1285=1
References
#1165439
Cross- CVE-2020-1747
Affected Products:
SUSE OpenStack Cloud Crowbar 8
SUSE OpenStack Cloud 8
SUSE OpenStack Cloud 7
SUSE OpenStack Cloud 6-LTSS
SUSE Manager Tools 12
SUSE Manager Server 3.2
SUSE Manager Proxy 3.2
SUSE Linux Enterprise Server for SAP 12-SP3
SUSE Linux Enterprise Server 12-SP5
SUSE Linux Enterprise Server 12-SP4
SUSE Linux Enterprise Server 12-SP3-LTSS
SUSE Linux Enterprise Server 12-SP3-BCL
SUSE Linux Enterprise Point of Sale 12-SP2
SUSE Linux Enterprise Module for Public Cloud 12
SUSE Linux Enterprise Module for Containers 12
SUSE Linux Enterprise Module for Advanced Systems Management 12
SUSE Linux Enterprise High Availability 1...
Read the Full Advisory
PREVIOUS
NEXT
Severity
important
Lowest
Low
Medium
High
Critical
Announcement ID: SUSE-SU-2020:1285-1
Rating: important
Get the latest News and Insights
Get the latest Linux and open source security news straight to your inbox.
Related News
Powered By
Linux Security - Your source for Top Linux News, Advisories, HOWTOs and Feature Releases
QUICK LINKS
subscribe to newsletters!
Like staying secure? So do we.
Sign up for updates, tips, and alerts!